Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1 study found for:    12480560 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Active, not recruiting L-ornithine L-aspartate in Overt Hepatic Encephalopathy
Conditions: Cirrhosis of Liver;   Hepatic Encephalopathy
Interventions: Drug: L-ornithine L-aspartate;   Drug: Placebo

Study has passed its completion date and status has not been verified in more than two years.